Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year - Top-Institutions - MDSpire

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • By

  • Diamant Thaçi

  • Akihiko Asahina

  • Wolf-Henning Boehncke

  • Alice B. Gottlieb

  • Mark Lebwohl

  • Richard B. Warren

  • Heather Edens

  • Barbara Ink

  • Rajan Bajracharya

  • Jason Coarse

  • Joseph F. Merola

  • December 12, 2025

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Hospital for Special Surgery
    Hospital for Special Surgery

    New York, NY

    Key Differentiators

    • Rheumatology
    • Orthopedics
    • Dermatology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Dermatology
    • Immunology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Dermatology
    • Clinical Research

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Dermatology
    • Immunology

  • #5

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Rheumatology
    • Dermatology
    • Translational Medicine

Original Source(s)

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • by Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, Alice B. Gottlieb, Mark Lebwohl, Richard B. Warren, Heather Edens, Barbara Ink, Rajan Bajracharya, Jason Coarse, Joseph F. Merola

  • December 12, 2025

Related Content

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Efficacy and Safety of Deucravacitinib for Psoriasis: A Multicenter Real-World Analysis Focusing on Scalp Outcomes—IL PSO (Italian Landscape Psoriasis)

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.